CLIPing the brain: studies of protein-RNA interactions important for neurodegenerative disorders

Miha Modic1, Jernej Ule, Christopher R Sibley

  • 1MRC Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 0QH, UK; Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Feodor-Lynen-Strasse 25, 81377 Munich, Germany.

Insights

RNA binding proteins (RBPs) control mRNA fate and are implicated in neurologic diseases. This review details how UV-induced cross-linked immunoprecipitation (CLIP) and related methods reveal RBP functions in the brain and their role in neurodegeneration.

Area of Science:

  • Molecular Biology
  • Neuroscience
  • Genomics

Background:

  • RNA binding proteins (RBPs) are crucial regulators of mRNA processing, stability, localization, and translation.
  • Dysfunctional RBPs are linked to severe central nervous system disorders, including frontotemporal lobar degeneration, amyotrophic lateral sclerosis, and fragile X syndrome.

Purpose of the Study:

  • To review studies integrating UV-induced cross-linked immunoprecipitation (CLIP) with genome-wide techniques to characterize RBP functions in the brain.
  • To discuss technical challenges and strategies for identifying RBP-bound and -regulated RNAs.
  • To highlight the role of CLIP and related methods in understanding RBPs in neurologic diseases.

Main Methods:

  • Integration of UV-induced cross-linked immunoprecipitation (CLIP) with other genome-wide approaches.
  • Analysis of studies characterizing diverse RBPs in the brain.
  • Review of strategies for reliable identification of RNA targets.

Main Results:

  • CLIP-based methods provide comprehensive functional characterization of RBPs in neural tissues.
  • These techniques are essential for identifying specific RNA targets and regulatory mechanisms of RBPs.
  • The application of CLIP has advanced the understanding of RBP involvement in neurodegenerative conditions.

Conclusions:

  • UV-induced cross-linked immunoprecipitation (CLIP) and associated techniques are powerful tools for studying RNA binding protein (RBP) function.
  • These methods are instrumental in elucidating the mechanisms underlying RBP-associated neurologic diseases.
  • Continued application of CLIP will further unravel the complexities of RNA regulation in neurodegeneration.

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Nonsense-mediated mRNA Decay02:27

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...